We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Predictive Model for Daily Risk Alerts in Sepsis Patients Enables Early Intervention

By HospiMedica International staff writers
Posted on 18 Mar 2025

Sepsis, a life-threatening condition caused by the body’s unregulated response to infection, remains one of the leading causes of death in ICUs globally. More...

Despite advancements in medical technology, accurately predicting sepsis outcomes continues to pose a major challenge. Traditional scoring systems, such as APACHE-II, often fail to provide timely and precise risk assessments. A new predictive model that delivers daily risk alerts for sepsis patients in the ICU represents a significant breakthrough in critical care.

A team of researchers from Sichuan University (Chengdu, China) and their collaborators have developed a two-stage Transformer-based model designed to process hourly and daily time-series data from ICU patients. Trained on data from over 13,000 sepsis patients, this model demonstrated strong predictive capabilities, achieving an AUC of 0.92 by the fifth day of ICU admission. This improvement highlights the model's ability to integrate longitudinal physiological patterns, providing clinicians with an effective tool for early intervention.

The study, published in Precision Clinical Medicine, also employed SHAP-derived temporal heatmaps to illustrate the dynamics of mortality-associated features over time. These heatmaps identified key biomarkers, such as lactate levels, tidal volume, and chloride levels, that are strongly correlated with patient outcomes. This visualization bridges the gap between model predictions and clinically interpretable biomarkers, offering clinicians valuable insights. The model’s external validation, which included both Chinese sepsis data and the MIMIC-IV database, confirmed its generalizability. With an accuracy of 81.8% on Chinese data and 76.56% on MIMIC-IV, the model demonstrates its adaptability across diverse populations and healthcare environments.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.